Advertisement

Infection Control and Prevention After Dismounted Complex Blast Injury

  • Heather C. Yun
  • Dana M. Blyth
  • Clinton K. Murray
Chapter

Abstract

During recent operations in Afghanistan, dismounted complex blast injuries (DCBI) have become increasingly common, and due to improvements in combat casualty care, these injuries are more survivable than they have been at any time in history. These patients are at high risk for infectious complications with infection rates as high as 50% in intensive care unit patients. The pathogens involved are often unique, including multidrug-resistant organisms and invasive fungi. This chapter summarizes the current literature on the epidemiology, microbiology, and outcomes of infectious complications in the predominantly DCBI combat casualty population and defines recommended measures for preventing these complications. These include wound management, use of antimicrobials, and both strategic and tactical infection prevention and control priorities. These recommendations are applicable throughout the continuum of casualty care with an emphasis on preventing infection beginning from the time of injury.

Keywords

Combat Military Trauma Infection Prevention Wound 

Notes

Conflicts of Interest

The authors declare no conflicts of interest and no funding source used in the preparation of this manuscript.

Disclaimer

The views expressed herein are those of the authors and do not reflect the official policy or position of Brooke Army Medical Center, the US Army Medical Department, the US Army Office of the Surgeon General, the Department of the Air Force, the Department of the Army, the Department of Defense, or the US Government.

References

  1. 1.
    Dismounted complex blast injury: report of the army dismounted complex blast injury task force. 2011.Google Scholar
  2. 2.
    Center AFHS. Deployment-related conditions of special surveillance interest. Med Surveill Mon Rep. 2012;19(4):25.Google Scholar
  3. 3.
    Krueger CA, Wenke JC, Ficke JR. Ten years at war: comprehensive analysis of amputation trends. J Trauma Acute Care Surg. 2012;73(6 Suppl 5):S438–44.CrossRefGoogle Scholar
  4. 4.
    Reilly C. A chance in hell, part 3: blood and grit. The Virginian-Pilot, 2011, 2.Google Scholar
  5. 5.
    Tribble DR, Conger NG, Fraser S, Gleeson TD, Wilkins K, Antonille T, et al. Infection-associated clinical outcomes in hospitalized medical evacuees after traumatic injury: trauma infectious disease outcome study. J Trauma. 2011;71(1 Suppl):S33–42.CrossRefGoogle Scholar
  6. 6.
    Tribble DR, Li P, Warkentien TE, Lloyd BA, Schnaubelt ER, Ganesan A, et al. Impact of operational theater on combat and noncombat trauma-related infections. Mil Med. 2016;181(10):1258–68.CrossRefGoogle Scholar
  7. 7.
    Centers for Disease C, Prevention. Acinetobacter Baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002-2004. MMWR Morb Mortal Wkly Rep. 2004;53(45):1063–6.Google Scholar
  8. 8.
    Murray CK, Roop SA, Hospenthal DR, Dooley DP, Wenner K, Hammock J, et al. Bacteriology of war wounds at the time of injury. Mil Med. 2006;171(9):826–9.CrossRefGoogle Scholar
  9. 9.
    Yun HC, Murray CK, Roop SA, Hospenthal DR, Gourdine E, Dooley DP. Bacteria recovered from patients admitted to a deployed U.S. military hospital in Baghdad, Iraq. Mil Med. 2006;171(9):821–5.CrossRefGoogle Scholar
  10. 10.
    Johnson EN, Burns TC, Hayda RA, Hospenthal DR, Murray CK. Infectious complications of open type III tibial fractures among combat casualties. Clin Infect Dis Off Publ Infect Dis Soc Am. 2007;45(4):409–15.CrossRefGoogle Scholar
  11. 11.
    Yun HC, Branstetter JG, Murray CK. Osteomyelitis in military personnel wounded in Iraq and Afghanistan. J Trauma. 2008;64(2 Suppl):S163–8. discussion S8.CrossRefGoogle Scholar
  12. 12.
    Hospenthal DR, Crouch HK, English JF, Leach F, Pool J, Conger NG, et al. Multidrug-resistant bacterial colonization of combat-injured personnel at admission to medical centers after evacuation from Afghanistan and Iraq. J Trauma. 2011;71(1 Suppl):S52–7.CrossRefGoogle Scholar
  13. 13.
    Weintrob AC, Murray CK, Lloyd B, Li P, Lu D, Miao Z, et al. Active surveillance for asymptomatic colonization with multidrug-resistant gram negative bacilli among injured service members--a three year evaluation. Msmr. 2013;20(8):17–22.PubMedPubMedCentralGoogle Scholar
  14. 14.
    White BK, Mende K, Weintrob AC, Beckius ML, Zera WC, Lu D, et al. Epidemiology and antimicrobial susceptibilities of wound isolates of obligate anaerobes from combat casualties. Diagn Microbiol Infect Dis. 2016;84(2):144–50.CrossRefGoogle Scholar
  15. 15.
    Blyth DM, Mende K, Weintrob AC, Beckius ML, Zera WC, Bradley W, et al. Resistance patterns and clinical significance of Candida colonization and infection in combat-related injured patients from iraq and afghanistan. Open Forum Infect Dis. 2014;1(3):ofu109.CrossRefGoogle Scholar
  16. 16.
    Tong MJ. Septic complications of war wounds. JAMA. 1972;219(8):1044–7.CrossRefGoogle Scholar
  17. 17.
    Murray CK, Yun HC, Griffith ME, Hospenthal DR, Tong MJ. Acinetobacter infection: what was the true impact during the Vietnam conflict? Clin Infect Dis Off Publ Infect Dis Soc Am. 2006;43(3):383–4.CrossRefGoogle Scholar
  18. 18.
    Wallum TE, Yun HC, Rini EA, Carter K, Guymon CH, Akers KS, et al. Pathogens present in acute mangled extremities from Afghanistan and subsequent pathogen recovery. Mil Med. 2015;180(1):97–103.CrossRefGoogle Scholar
  19. 19.
    Keen EF, Mende K, Yun HC, Aldous WK, Wallum TE, Guymon CH, et al. Evaluation of potential environmental contamination sources for the presence of multidrug-resistant bacteria linked to wound infections in combat casualties. Infect Control Hosp Epidemiol Off J Soc Hosp Epidemiol Am. 2012;33(9):905–11.CrossRefGoogle Scholar
  20. 20.
    Griffith ME, Ceremuga JM, Ellis MW, Guymon CH, Hospenthal DR, Murray CK. Acinetobacter skin colonization of US Army soldiers. Infect Control Hosp Epidemiol Off J Soc Hosp Epidemiol Am. 2006;27(7):659–61.CrossRefGoogle Scholar
  21. 21.
    Griffith ME, Lazarus DR, Mann PB, Boger JA, Hospenthal DR, Murray CK. Acinetobacter skin carriage among US army soldiers deployed in Iraq. Infect Control Hosp Epidemiol Off J Soc Hosp Epidemiol Am. 2007;28(6):720–2.CrossRefGoogle Scholar
  22. 22.
    Scott P, Deye G, Srinivasan A, Murray C, Moran K, Hulten E, et al. An outbreak of multidrug-resistant Acinetobacter Baumannii-Calcoaceticus Complex infection in the US military health care system associated with military operations in Iraq. Clin Infect Dis Off Publ Infect Dis Soc Am. 2007;44(12):1577–84.CrossRefGoogle Scholar
  23. 23.
    Tangden T, Cars O, Melhus A, Lowdin E. Foreign travel is a major risk factor for colonization with Escherichia Coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers. Antimicrob Agents Chemother. 2010;54(9):3564–8.CrossRefGoogle Scholar
  24. 24.
    Ostholm-Balkhed A, Tarnberg M, Nilsson M, Nilsson LE, Hanberger H, Hallgren A, et al. Travel-associated faecal colonization with ESBL-producing Enterobacteriaceae: incidence and risk factors. J Antimicrob Chemother. 2013;68(9):2144–53.CrossRefGoogle Scholar
  25. 25.
    Laupland KB, Church DL, Vidakovich J, Mucenski M, Pitout JD. Community-onset extended-spectrum beta-lactamase (ESBL) producing Escherichia Coli: importance of international travel. J Infect. 2008;57(6):441–8.CrossRefGoogle Scholar
  26. 26.
    Vento TJ, Cole DW, Mende K, Calvano TP, Rini EA, Tully CC, et al. Multidrug-resistant gram-negative bacteria colonization of healthy US military personnel in the US and Afghanistan. BMC Infect Dis. 2013;13:68.CrossRefGoogle Scholar
  27. 27.
    Janvier F, Delacour H, Tesse S, Larreche S, Sanmartin N, Ollat D, et al. Faecal carriage of extended-spectrum beta-lactamase-producing enterobacteria among soldiers at admission in a French military hospital after aeromedical evacuation from overseas. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol. 2014;33:1719.CrossRefGoogle Scholar
  28. 28.
    Mende K, Beckius ML, Zera WC, Yu X, Cheatle KA, Aggarwal D, et al. Phenotypic and genotypic changes over time and across facilities of serial colonizing and infecting Escherichia Coli isolates recovered from injured service members. J Clin Microbiol. 2014;52(11):3869–77.CrossRefGoogle Scholar
  29. 29.
    Griffith ME, Gonzalez RS, Holcomb JB, Hospenthal DR, Wortmann GW, Murray CK. Factors associated with recovery of Acinetobacter Baumannii in a combat support hospital. Infect Control Hosp Epidemiol Off J Soc Hosp Epidemiol Am. 2008;29(7):664–6.CrossRefGoogle Scholar
  30. 30.
    Turton JF, Kaufmann ME, Gill MJ, Pike R, Scott PT, Fishbain J, et al. Comparison of Acinetobacter Baumannii isolates from the United Kingdom and the United States that were associated with repatriated casualties of the Iraq conflict. J Clin Microbiol. 2006;44(7):2630–4.CrossRefGoogle Scholar
  31. 31.
    Ake J, Scott P, Wortmann G, Huang XZ, Barber M, Wang Z, et al. Gram-negative multidrug-resistant organism colonization in a US military healthcare facility in Iraq. Infect Control Hosp Epidemiol Off J Soc Hosp Epidemiol Am. 2011;32(6):545–52.CrossRefGoogle Scholar
  32. 32.
    Huang XZ, Frye JG, Chahine MA, Glenn LM, Ake JA, Su W, et al. Characteristics of plasmids in multi-drug-resistant Enterobacteriaceae isolated during prospective surveillance of a newly opened hospital in Iraq. PLoS One. 2012;7(7):e40360.CrossRefGoogle Scholar
  33. 33.
    Sutter DE, Bradshaw LU, Simkins LH, Summers AM, Atha M, Elwood RL, et al. High incidence of multidrug-resistant gram-negative bacteria recovered from Afghan patients at a deployed US military hospital. Infect Control Hosp Epidemiol Off J Soc Hosp Epidemiol Am. 2011;32(9):854–60.CrossRefGoogle Scholar
  34. 34.
    Warkentien T, Rodriguez C, Lloyd B, Wells J, Weintrob A, Dunne JR, et al. Invasive mold infections following combat-related injuries. Clin Infect Dis Off Publ Infect Dis Soc Am. 2012;55(11):1441–9.CrossRefGoogle Scholar
  35. 35.
    Weintrob AC, Weisbrod AB, Dunne JR, Rodriguez CJ, Malone D, Lloyd BA, et al. Combat trauma-associated invasive fungal wound infections: epidemiology and clinical classification. Epidemiol Infect. 2015:143(1):214–24.CrossRefGoogle Scholar
  36. 36.
    Rodriguez CJ, Weintrob AC, Shah J, Malone D, Dunne JR, Weisbrod AB, et al. Risk factors associated with invasive fungal infections in combat trauma. Surg Infect. 2014;15:521.CrossRefGoogle Scholar
  37. 37.
    Tribble DR, Rodriguez CJ, Weintrob AC, Shaikh F, Aggarwal D, Carson ML, et al. Environmental factors related to fungal wound contamination after combat trauma in Afghanistan, 2009-2011. Emerg Infect Dis. 2015;21(10):1759–69.CrossRefGoogle Scholar
  38. 38.
    Warkentien TE, Shaikh F, Weintrob AC, Rodriguez CJ, Murray CK, Lloyd BA, et al. Impact of Mucorales and other invasive molds on clinical outcomes of Polymicrobial traumatic wound infections. J Clin Microbiol. 2015;53(7):2262–70.CrossRefGoogle Scholar
  39. 39.
    Burns TC, Stinner DJ, Mack AW, Potter BK, Beer R, Eckel TT, et al. Microbiology and injury characteristics in severe open tibia fractures from combat. J Trauma Acute Care Surgery. 2012;72(4):1062–7.CrossRefGoogle Scholar
  40. 40.
    Napierala MA, Rivera JC, Burns TC, Murray CK, Wenke JC, Hsu JR, et al. Infection reduces return-to-duty rates for soldiers with type III open tibia fractures. J Trauma Acute Care Surgery. 2014;77(3 Suppl 2):S194–7.CrossRefGoogle Scholar
  41. 41.
    Huh J, Stinner DJ, Burns TC, Hsu JR, Late Amputation Study T. Infectious complications and soft tissue injury contribute to late amputation after severe lower extremity trauma. J Trauma. 2011;71(1 Suppl):S47–51.CrossRefGoogle Scholar
  42. 42.
    Masini BD, Owens BD, Hsu JR, Wenke JC. Rehospitalization after combat injury. J Trauma. 2011;71(1 Suppl):S98–102.CrossRefGoogle Scholar
  43. 43.
    Kelly JF, Ritenour AE, McLaughlin DF, Bagg KA, Apodaca AN, Mallak CT, et al. Injury severity and causes of death from operation Iraqi freedom and operation enduring freedom: 2003-2004 versus 2006. J Trauma. 2008;64(2 Suppl):S21–6. discussion S6-7.CrossRefGoogle Scholar
  44. 44.
    Holcomb JB, McMullin NR, Pearse L, Caruso J, Wade CE, Oetjen-Gerdes L, et al. Causes of death in U.S. special operations forces in the global war on terrorism: 2001-2004. Ann Surg. 2007;245(6):986–91.CrossRefGoogle Scholar
  45. 45.
    Lewandowski LR, Weintrob AC, Tribble DR, Rodriguez CJ, Petfield J, Lloyd BA, et al. Early complications and outcomes in combat injury-related invasive fungal wound infections: a case-control analysis. J Orthop Trauma. 2016;30(3):e93–9.CrossRefGoogle Scholar
  46. 46.
    Hospenthal DR, Green AD, Crouch HK, English JF, Pool J, Yun HC, et al. Infection prevention and control in deployed military medical treatment facilities. J Trauma. 2011;71(2 Suppl 2):S290–8.CrossRefGoogle Scholar
  47. 47.
    Investigators F, Bhandari M, Jeray KJ, Petrisor BA, Devereaux PJ, Heels-Ansdell D, et al. A trial of wound irrigation in the initial management of open fracture wounds. N Engl J Med. 2015;373(27):2629–41.CrossRefGoogle Scholar
  48. 48.
    Owens BD, White DW, Wenke JC. Comparison of irrigation solutions and devices in a contaminated musculoskeletal wound survival model. J Bone Joint Surg Am. 2009;91(1):92–8.CrossRefGoogle Scholar
  49. 49.
    Maragakis LL, Cosgrove SE, Song X, Kim D, Rosenbaum P, Ciesla N, et al. An outbreak of multidrug-resistant Acinetobacter Baumannii associated with pulsatile lavage wound treatment. JAMA. 2004;292(24):3006–11.CrossRefGoogle Scholar
  50. 50.
    Lalliss SJ, Stinner DJ, Waterman SM, Branstetter JG, Masini BD, Wenke JC. Negative pressure wound therapy reduces pseudomonas wound contamination more than Staphylococcus Aureus. J Orthop Trauma. 2010;24(9):598–602.CrossRefGoogle Scholar
  51. 51.
    Murray CK, Obremskey WT, Hsu JR, Andersen RC, Calhoun JH, Clasper JC, et al. Prevention of infections associated with combat-related extremity injuries. J Trauma Inj Infect Crit Care. 2011;71:S235–S57.CrossRefGoogle Scholar
  52. 52.
    Moues CM, Vos MC, van den Bemd GJ, Stijnen T, Hovius SE. Bacterial load in relation to vacuum-assisted closure wound therapy: a prospective randomized trial. Wound Repair Regen. 2004;12(1):11–7.CrossRefGoogle Scholar
  53. 53.
    Pollak AN. Timing of debridement of open fractures. J Am Acad Orthop Surg. 2006;14(10 Spec No.):S48–51.CrossRefGoogle Scholar
  54. 54.
    Weber D, Dulai SK, Bergman J, Buckley R, Beaupre LA. Time to initial operative treatment following open fracture does not impact development of deep infection: a prospective cohort study of 736 subjects. J Orthop Trauma. 2014;28(11):613–9.CrossRefGoogle Scholar
  55. 55.
    Giannou C, Baldan M, for the International Committee of the Red Cross. War surgery: working with limited resources in armed conflict and other situations of violence, vol. 1; 2010. p. Geneva–ICRC.Google Scholar
  56. 56.
    Dharm-Datta S, McLenaghan J. Medical lessons learnt from the US and Canadian experience of treating combat casualties from Afghanistan and Iraq. J R Army Med Corps. 2013;159(2):102–9.CrossRefGoogle Scholar
  57. 57.
    Hospenthal DR, Murray CK, Andersen RC, Bell RB, Calhoun JH, Cancio LC, et al. Guidelines for the prevention of infections associated with combat-related injuries: 2011 update: endorsed by the Infectious Diseases Society of America and the Surgical Infection Society. J Trauma. 2011;71(2 Suppl 2):S210–34.CrossRefGoogle Scholar
  58. 58.
    Hauser CJ, Adams CA Jr, Eachempati SR, Council of the Surgical Infection S. Surgical Infection Society guideline: prophylactic antibiotic use in open fractures: an evidence-based guideline. Surg Infect. 2006;7(4):379–405.CrossRefGoogle Scholar
  59. 59.
    Hoff WS, Bonadies JA, Cachecho R, Dorlac WC. East practice management guidelines work group: update to practice management guidelines for prophylactic antibiotic use in open fractures. J Trauma. 2011;70(3):751–4.CrossRefGoogle Scholar
  60. 60.
    Gilbert LJ, Li P, Murray CK, Yun HC, Aggarwal D, Weintrob AC, et al. Multidrug-resistant gram-negative bacilli colonization risk factors among trauma patients. Diagn Microbiol Infect Dis. 2016;84(4):358–60.CrossRefGoogle Scholar
  61. 61.
    Lloyd B, Murray CK, Shaikh F, Schnaubelt E, Whitman T, Blyth DM, Carson L, Tribble DR. Addition of fluoroquinolones or aminoglycosides to post-trauma antibiotic prophylaxis does not decrease risk of early osteomyelitis. IDWeek; 28 October 2016; New Orleans, LA, 2016.Google Scholar
  62. 62.
    Murray CK, Yun HC, Griffith ME, Thompson B, Crouch HK, Monson LS, et al. Recovery of multidrug-resistant bacteria from combat personnel evacuated from Iraq and Afghanistan at a single military treatment facility. Mil Med. 2009;174(6):598–604.CrossRefGoogle Scholar
  63. 63.
    Barsoumian A, Sanchez CJ, Mende K, Tully CC, Beckius ML, Akers KS, et al. In vitro toxicity and activity of Dakin's solution, mafenide acetate, and amphotericin B on filamentous fungi and human cells. J Orthop Trauma. 2013;27(8):428–36.CrossRefGoogle Scholar
  64. 64.
    Joint Theater Trauma System Clinical Practice Guideline: Invasive Fungal Infection in War Wounds. 2016.Google Scholar
  65. 65.
    Hospenthal DR, Crouch HK, English JF, Leach F, Pool J, Conger NG, et al. Response to infection control challenges in the deployed setting: operations Iraqi and enduring freedom. J Trauma. 2010;69(Suppl 1):S94–101.CrossRefGoogle Scholar
  66. 66.
    Yun HC, Murray CK. Infection prevention in the deployed environment. US Army Med Dep J. 2016;(2–16):114–8.Google Scholar
  67. 67.
    Hospenthal DR, Murray CK, Andersen RC, Blice JP, Calhoun JH, Cancio LC, et al. Guidelines for the prevention of infection after combat-related injuries. J Trauma. 2008;64(3 Suppl):S211–20.CrossRefGoogle Scholar
  68. 68.
    Yun HC, Weintrob AC, Conger NG, Li P, Lu D, Tribble DR, et al. Healthcare-associated pneumonia among U.S. combat casualties, 2009 to 2010. Mil Med. 2015;180(1):104–10.CrossRefGoogle Scholar
  69. 69.
    Joint Theater Trauma System Clinical Practice Guideline: Ventilator Associated Pneumonia 2012 [Available from: http://www.usaisr.amedd.army.mil/assets/cpgs/Ventilator_Associated_Pneumonia_17_Jul_12.pdf.
  70. 70.
    Landrum ML, Murray CK. Ventilator associated pneumonia in a military deployed setting: the impact of an aggressive infection control program. J Trauma. 2008;64(2 Suppl):S123–7. discussion S7-8.CrossRefGoogle Scholar
  71. 71.
    Anderson DJ, Kaye KS, Classen D, Arias KM, Podgorny K, Burstin H, et al. Strategies to prevent surgical site infections in acute care hospitals. Infect Control Hosp Epidemiol Off J Soc Hosp Epidemiol Am. 2008;29(Suppl 1):S51–61.CrossRefGoogle Scholar
  72. 72.
    Bratzler DW, Hunt DR. The surgical infection prevention and surgical care improvement projects: national initiatives to improve outcomes for patients having surgery. Clin Infect Dis Off Publ Infect Dis Soc Am. 2006;43(3):322–30.CrossRefGoogle Scholar
  73. 73.
    de Vries EN, Prins HA, Crolla RM, den Outer AJ, van Andel G, van Helden SH, et al. Effect of a comprehensive surgical safety system on patient outcomes. N Engl J Med. 2010;363(20):1928–37.CrossRefGoogle Scholar
  74. 74.
    Darouiche RO, Wall MJ Jr, Itani KM, Otterson MF, Webb AL, Carrick MM, et al. Chlorhexidine-alcohol versus Povidone-iodine for surgical-site antisepsis. N Engl J Med. 2010;362(1):18–26.CrossRefGoogle Scholar
  75. 75.
    Tribble DR, Lloyd B, Weintrob A, Ganesan A, Murray CK, Li P, et al. Antimicrobial prescribing practices following publication of guidelines for the prevention of infections associated with combat-related injuries. J Trauma. 2011;71(2 Suppl 2):S299–306.CrossRefGoogle Scholar
  76. 76.
    Lloyd BA, Weintrob AC, Hinkle MK, Fortuna GR, Murray CK, Bradley W, et al. Adherence to published antimicrobial prophylaxis guidelines for wounded service members in the ongoing conflicts in Southwest Asia. Mil Med. 2014;179(3):324–8.CrossRefGoogle Scholar
  77. 77.
    Yun HC, Murray CK. Practical approach to combat-related infections and antibiotics. In: Martin M, Beekley A, Eckert M, editors. Front Line Surgery: Switzerland: Springer International Publishing; 2017.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Heather C. Yun
    • 1
    • 2
  • Dana M. Blyth
    • 1
    • 2
  • Clinton K. Murray
    • 1
    • 2
  1. 1.San Antonio Military Medical CenterJBSA-Fort Sam HoustonUSA
  2. 2.Uniformed Services University of the Health SciencesBethesdaUSA

Personalised recommendations